17 results

e1 Significance of elevated SCC-Ag level on tumor recurrence and patient survival in patients with squamous-cell carcinoma of uterine cervix following definitive chemoradiotherapy: a multi-institutional analysis
Kyu Hye Choi, Sea-Won Lee, Mina Yu, Songmi Jeong, Jeong Won Lee, Jong Hoon Lee
J Gynecol Oncol. 2019;30(1):e1.  Published online 2018 August 30    DOI: http://dx.doi.org/10.3802/jgo.2019.30.e1
         
e2 Factors influencing decision-making around opportunistic salpingectomy: a nationwide survey
Miranda P. Steenbeek, Laura A.M. van Lieshout, Johanna W.M. Aarts, Jurgen M.J. Piek, Sjors F.P.J. Coppus, Leon F.A.G. Massuger, Rosella P.M.G. Hermens, Joanne A. de Hullu
J Gynecol Oncol. 2019;30(1):e2.  Published online 2018 August 31    DOI: http://dx.doi.org/10.3802/jgo.2019.30.e2
         
e3 Incorporation of paclitaxel-based hyperthermic intraperitoneal chemotherapy in patients with advanced-stage ovarian cancer treated with neoadjuvant chemotherapy followed by interval debulking surgery: a protocol-based pilot study
Yong Jae Lee, Jung-Yun Lee, Min-Soo Cho, Eun Ji Nam, Sang Wun Kim, Sunghoon Kim, Young Tae Kim
J Gynecol Oncol. 2019;30(1):e3.  Published online 2018 September 10    DOI: http://dx.doi.org/10.3802/jgo.2019.30.e3
         
e4 The detrimental effect of adopting interval debulking surgery in advanced stage low-grade serous ovarian cancer
Giorgio Bogani, Umberto Leone Roberti Maggiore, Biagio Paolini, Antonino Diito, Fabio Martinelli, Domenica Lorusso, Francesco Raspagliesi
J Gynecol Oncol. 2019;30(1):e4.  Published online 2018 September 12    DOI: http://dx.doi.org/10.3802/jgo.2019.30.e4
         
e5 Association of pretreatment thrombocytosis with prognosis in ovarian cancer: a systematic review and meta-analysis
Qingjian Ye, Juan Cheng, Minjuan Ye, Dong Liu, Yu Zhang
J Gynecol Oncol. 2019;30(1):e5.  Published online 2018 September 10    DOI: http://dx.doi.org/10.3802/jgo.2019.30.e5
         
e6 The age-adjusted Charlson comorbidity index as a predictor of survival in surgically treated vulvar cancer patients
Violante Di Donato, Zoe Page, Carlotta Bracchi, Federica Tomao, Angela Musella, Giorgia Perniola, Pierluigi Benedetti Panici
J Gynecol Oncol. 2019;30(1):e6.  Published online 2018 October 4    DOI: http://dx.doi.org/10.3802/jgo.2019.30.e6
         
e7 Prognostic factors of synchronous endometrial and ovarian endometrioid carcinoma
Yutaka Yoneoka, Hiroshi Yoshida, Mitsuya Ishikawa, Hanako Shimizu, Takashi Uehara, Takashi Murakami, Tomoyasu Kato
J Gynecol Oncol. 2019;30(1):e7.  Published online 2018 September 17    DOI: http://dx.doi.org/10.3802/jgo.2019.30.e7
         
e8 A novel prediction score for predicting the baseline risk of recurrence of stage I–II endometrial carcinoma
Kenta Takahashi, Mayu Yunokawa, Shinsuke Sasada, Yae Takehara, Naoyuki Miyasaka, Tomoyasu Kato, Kenji Tamura
J Gynecol Oncol. 2019;30(1):e8.  Published online 2018 October 2    DOI: http://dx.doi.org/10.3802/jgo.2019.30.e8
         
e9 Efficacy and dosimetry analysis of image-guided radioactive 125I seed implantation as salvage treatment for pelvic recurrent cervical cancer after external beam radiotherapy
Ang Qu, Ping Jiang, Haitao Sun, Weijuan Jiang, Yuliang Jiang, Suqing Tian, Junjie Wang
J Gynecol Oncol. 2019;30(1):e9.  Published online 2018 October 30    DOI: http://dx.doi.org/10.3802/jgo.2019.30.e9
         
e10 Current state and outlook for drug repositioning anticipated in the field of ovarian cancer
Yusuke Kobayashi, Kouji Banno, Haruko Kunitomi, Eiichiro Tominaga, Daisuke Aoki
J Gynecol Oncol. 2019;30(1):e10.  Published online 2018 October 8    DOI: http://dx.doi.org/10.3802/jgo.2019.30.e10
         
e11 Optimal cutoff age for predicting prognosis associated with serous epithelial ovarian cancer: what is the best age cutoff?
Jihye Kim, Youjean Chang, Tae-Joong Kim, Jeong-Won Lee, Byoung-Gie Kim, Duk-Soo Bae, Chel Hun Choi
J Gynecol Oncol. 2019;30(1):e11.  Published online 2018 October 22    DOI: http://dx.doi.org/10.3802/jgo.2019.30.e11
         
e12 Serum calcium is a novel parameter to assess metabolic syndrome in endometrial carcinoma
Yanying Lin, Jingyi Zhou, Linlin Cao, Qi Xu, Juan Hao, Lijun Zhao, Jianliu Wang
J Gynecol Oncol. 2019;30(1):e12.  Published online 2018 October 11    DOI: http://dx.doi.org/10.3802/jgo.2019.30.e12
         
e13 The prognostic significance of estrogen and progesterone receptors in grade I and II endometrioid endometrial adenocarcinoma: hormone receptors in risk stratification
Jun Guan, Liying Xie, Xuezhen Luo, Bingyi Yang, Hongwei Zhang, Qin Zhu, Xiaojun Chen
J Gynecol Oncol. 2019;30(1):e13.  Published online 2018 October 29    DOI: http://dx.doi.org/10.3802/jgo.2019.30.e13
         
e14 Peritoneal cancer index in ovarian cancer
Wonkyo Shin, Sang-Yoon Park, Myong Cheol Lim
J Gynecol Oncol. 2019;30(1):e14.  Published online 2018 October 11    DOI: http://dx.doi.org/10.3802/jgo.2019.30.e14
         
e30 Tailoring radicality in early cervical cancer: how far can we go?
Jacobus van der Velden, Constantijne H. Mom
J Gynecol Oncol. 2019;30(1):e30.  Published online 2018 November 22    DOI: http://dx.doi.org/10.3802/jgo.2019.30.e30
         
e33 Opportunistic salpingectomy in the Netherlands
Karl Tamussino
J Gynecol Oncol. 2019;30(1):e33.  Published online 2018 November 22    DOI: http://dx.doi.org/10.3802/jgo.2019.30.e33
         
e38 Incidence of cervical, endometrial, and ovarian cancer in Korea during 1999–2015
Myong Cheol Lim, Young-Joo Won, Mun Jung Ko, Miseon Kim, Seung-Hyuk Shim, Dong Hoon Suh, Jae-Weon Kim
J Gynecol Oncol. 2019;30(1):e38.  Published online 2018 December 19    DOI: http://dx.doi.org/10.3802/jgo.2019.30.e38
         
Articles from Journal of Gynecologic Oncology are provided here courtesy of Asian Society of Gynecologic Oncology; Korean Society of Gynecologic Oncology